Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 324
Selected: 0
NCT IDTitle
NCT05843162A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
NCT06044493MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
NCT05193565Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
NCT04258865A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348
NCT05719155Pharmacokinetics and Safety/Tolerability of CKD-379
NCT05108038A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
NCT06627322A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
NCT04673682A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845
NCT02156544Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT04746287Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects
NCT03849287Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults
NCT05335044Study to Evaluate the Safety and Pharmacokinetics of CKD-331
NCT02977065To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
NCT02811731Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
NCT05207761Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930
NCT04471441Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.
NCT05526703Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
NCT02498509Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
NCT06112678A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)
NCT05245084A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
NCT01028859Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT02589457Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet
NCT05587699The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
NCT02854748Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
NCT02480465Efficacy and Safety of Lobeglitazone Versus Sitagliptin
NCT06386328A Clinical Trial to Evaluate the Food Effect of CKD-378
NCT03428594CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis
NCT02645890Study to Compare the Safety and Pharmacokinetics of CKD-397
NCT03659149Pharmacokinetics and Safety Profile of CKD-333
NCT05566028The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes
NCT04069065Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)
NCT02916901Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers
NCT01297036Pharmacokinetic Comparisons of Two Donepezil Formulations
NCT03794492Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome
NCT04871646Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314
NCT05921435Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults
NCT01991145Allogeneic UCB Therapy With EPO in Children With CP
NCT02064556CKD-330 Drug-Drug Interaction Study (Amlodipine)
NCT02247505CKD-397 Drug-drug Interaction Study (B)
NCT02300467NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
NCT02494284Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
NCT04673695A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
NCT04511000Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
NCT07215637Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
NCT01743287The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee
NCT03346187A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
NCT05704621Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
NCT05599152Comparison of Myocardial Infarction Patients Who Were Prescribed a Novel Antiplatelet Agent or Clopidogrel
NCT02586311CKD-330 Phase 3 Trial in Amlodipine Non-responder
NCT01016626Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet